Fatpos Global has released a report titled “Genomics Personalized Health Market - Analysis of Market Size, Share & Trends for 2021 – 2022 and Forecasts to 2032” which is anticipated to reach USD 31.46 Billion by 2032. According to a study by Fatpos Global, the market is anticipated to portray a CAGR of 12.5% between 2022 and 2032. As per the report, increased government and diagnostic health care spending is anticipated to play a significant role in driving the growth of the global genomics personalized health market. Furthermore, the need for genomics-based personalized health is projected to increase in the next years due to the high prevalence of certain chronic diseases, including cancer and diabetes.
“Biomarkers are crucial in determining the physiological state of the patient who has been diagnosed with a certain disease. Therefore, the increase in the number of people with chronic conditions like tumors and diabetes has fueled the demand for disease diagnostics, which in turn is fueling the expansion of the genomics personalized health market. The development of the pharmaceutical sector, and also accurate disease diagnosis and monitoring of the treatment response, are supporting the increase in demand for genomics personalized health solutions globally.”, said a lead analyst at Fatpos Global.
Personalized medicine is a developing medicine practice that uses a person’s genetic profile to escort the decisions made for the diagnosis, prevention, and cure of disease. Doctors can choose the best treatment and deliver it with the right dosage or regimen by having the right knowledge of the genetic profile of a patient. Since genomics gives us a very specific molecular window for the differences between us and allows the experts to make individualized predictions about disease risk, which can help someone choose the right prevention plan for them, genomics has a significant impact on the development of personalized medicine. Most of the time, it is also capable of choosing the ideal drug with the right dose for the right patient instead of the approach "one size fits all" to drug therapy.
Genomics Personalized Health market is categorized on the basis of End User into Academic Research Institutes, Diagnostic Centers, and Others. The academic research institutes and diagnostic centers are expected to lead the market over the forecast period, all of which held a significant market share in previous years. In the coming years, these categories are anticipated to be driven by rising genomics research activities, rising genetic disorders, rising strategic alliances between market leaders, and rising research institutes.
Some of the key players operating in the global Genomics Personalized Health Market are Thermo Fisher Scientific Inc., Illumina Inc., Vikor Scientific, Roche Holding AG, Qiagen, Quantgene , Bio-Rad Laboratories Inc., Lonza Group AG, ARCA biopharma, Invitae Corporation, Genetic Technologies Limited, Interleukin Genetics Inc., Eastern Biotech and Life Sciences, DNA Genotek Inc., XCode Life Sciences Private Limited., and Other Prominent Players.
In the latest market study conducted by, Fatpos Global thrives to present an unbiased analysis of the global Genomics Personalized Health Market that covers the historical demand data as well as the forecast figures for the period, i.e., 2022-2032. The study includes compelling insights into growth that is witnessed in the market. Global Genomics Personalized Health Market is classified on the basis of Test Type into Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, and Others. By Technology, the global Genomics Personalized Health Market is divided into NGS Platforms, RT-PCR, Microarray, and Genetic Analyzers. By End User, the global Genomics Personalized Health Market is divided into Academic Research Institutes, Diagnostic Centers, and Others. Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa.
About Fatpos Global
Fatpos Global is a leading management consulting, advisory, and market research organization that serves its clients globally through its team of experts and industry veterans that have years of expertise in management consulting, advisory, and market research analysis. The organization functions across business consulting, strategy consulting, market research, operations consulting, financial advisory, human resources, risk & compliance, environmental consulting, software consulting, and sales consulting amongst others, and aims to aid businesses with bold decisions that help them embrace change for their sustainable growth.
For more details, email: info@fatposglobal.com
Get in touch today to find out about how Evalueserve can help you mprove your processes, making you better, faster and more efficient.
